Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: A systematic review

References

• World Health Organization (WHO). Psoriasis: report by the Secretariat In: Board E, ed. 133rd session ed. Geneva, Switzerland: World Health Organization, 2013.
   Google Scholar
• Di Lernia V, Ficarelli E, Lallas A, Ricci C. Familial aggregation of moderate to severe plaque psoriasis. Clin Exp Dermatol. 2014;39:801–5.
   PubMed Web of Science ®Google Scholar
• Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol. 2014;70:146–7.
   PubMed Web of Science ®Google Scholar
• Biondi Oriente C, Scarpa R, Pucino A, Oriente P. Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Dermato-Venereol. 1989;146:69–71.
   Google Scholar
• Ayala F. Clinical presentation of psoriasis. Reumatismo. 2007;59:40–5.
   PubMedGoogle Scholar
• Clarke P. Psoriasis. Aust Fam Phys. 2011;40:468–73.
   PubMed Web of Science ®Google Scholar
• Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303:1–10.
   PubMed Web of Science ®Google Scholar
• (NHS) NHS. Psoriasis: The assessment and management of psoriasis. In: (NICE) NIfHacE, editor. Manchester, United Kingdom: NHS Evidence, 2012.
   Google Scholar
• Kupetsky EA, Keller M. Psoriasis vulgaris: an evidence-based guide for primary care. J Am Board Fam Med. 2013;26:787–801.
   PubMed Web of Science ®Google Scholar
• Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851–64.
   PubMed Web of Science ®Google Scholar
• Huang X, Zhang. L, Bie. X. Traditional Chinese medicine for the treatment of psoriasis vulgaris: A systematic review. Afr J Microbiol Res. 2012;6:7040–7.
   Google Scholar
• Zhang CS, Yu JJ, Parker S, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol. 2014;53:1305–18.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Zhang CS, Zhang AL, et al. Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: a systematic review. Evid-Based Complement Alternat Med. 2013;2013:673078.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S (Eds). Cochrane handbook for systematic reviews of interventions Version 5.1.0: updated March 2011. Oxford, United Kingdom: The Cochrane Collaboration, 2011.
   Google Scholar
• Man MQ, Shi Y, Man M, et al. Chinese herbal medicine (Tuhuai extract) exhibits topical anti-proliferative and anti-inflammatory activity in murine disease models. Exp Dermatol. 2008;17:681–7.
   PubMed Web of Science ®Google Scholar
• Tse WP, Cheng CH, Che CT, et al. Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: implications for psoriasis treatment. Inte J Mol Med. 2007;20:663–72.
   PubMed Web of Science ®Google Scholar
• Evidence-based guidelines of clinical practice in Chinese medicine specific disease. 1 ed. Beijing: China Press of Traditional Chinese Medicine, 2011.
   Google Scholar
• Chen A. Fu Fang Qing Dai Jiao Nang for psoriasis vulgaris: a double-blinded, randomised controlled trial]. Chin J Curr Traditional Western Med. 2005;3:1021–2.
   Google Scholar
• Wang ZC. Fu Fang Qing Dai capsule for the treatment of psoriasis - a randomised controlled trial. Chinese folk therapy. 2003;11:48–9.
   Google Scholar
• Ho SG, Yeung CK, Chan HH. Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life. Clin Exp Dermatol. 2010;35:717–22.
   PubMed Web of Science ®Google Scholar
• Dai YJ, Li YY, Zeng HM, et al. Effect of Yinxieling decoction on PASI, TNF-alpha and IL-8 in patients with psoriasis vulgaris. Asian Pac J Trop Med. 2014;7:668–70.
   PubMed Web of Science ®Google Scholar
• Zhang FR, Tian RM, Ma SY, Wang XY, Yu ML, Shi ZQ. Lei Gong Teng for treating psoriasis vulgaris in progressive stage - a randomised, double-blinded controlled trial. Journal of clinical dermatology. 1999;28:32–3.
   Google Scholar
• Zhou MJ, Wang H, Huang Y, Cui LP, Chen Y, Miao Y, et al. Liang Xue Huo Xue formula for treating psoriasis in progressive stage – the efficacy and safety. Chinese journal of dermatovenerology of integrated traditional and western medicine. 2012;11:152–4.
   Google Scholar
• Tan XY, Liu HW. 136 cases of comparing Chinese medicine with western medicine for the treatment of psoriasis vulgaris. China Foreign Medical Treatment. 20.08;27:57–8.
   Google Scholar
• Su XY, Wang JH, Wang F, Guo Q. Ke Yin He Ji for treating progressive stage psoriasis vulgaris – obversation of clinical symptoms and the change of bloood tnf-α, Tgf-β. Fujian journal of traditional Chinese medicine. 2010;41:12–3.
   Google Scholar
• Canter PH, Lee HS, Ernst E. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine. 2006;13:371–7.
   PubMed Web of Science ®Google Scholar
• Chan MA, Kohlmeier JE, Branden M, et al. Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. Phytother Res. 1999;13:464–7.
   PubMed Web of Science ®Google Scholar
• Clearinghouse N. Thunder God Vine. In: (ODS) OoDS, editor. United States: National Institutes of Health (NIH), 2007.
   Google Scholar
• Finlay AY, Khan GK. Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–16.
   PubMed Web of Science ®Google Scholar
• Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Quality Life Outcomes. 2006;4:35.
   PubMed Web of Science ®Google Scholar
• Gordon KB, Feldman SR, Koo JY, et al. Definitions of measures of effect duration for psoriasis treatments. Arch Dermatol. 2005;141:82–4.
   PubMed Web of Science ®Google Scholar
• Tobin AM, Kirby B. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs. 2005;19:47–57.
   PubMed Web of Science ®Google Scholar
• May BH, Deng S, Zhang AL, et al. In silico database screening of potential targets and pathways of compounds contained in plants used for psoriasis vulgaris. Arch Dermatol Res. 2015;307:645–57
   PubMed Web of Science ®Google Scholar
• Lv QW, Zhang W, Shi Q, et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis. 2015;74:1078–86.
   PubMed Web of Science ®Google Scholar
• Tao X, Younger J, Fan FZ, et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum. 2002;46:1735–43.
   PubMed Web of Science ®Google Scholar
• Ma J, Dey M, Yang H, et al. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry. 2007;68:1172–8.
   PubMed Web of Science ®Google Scholar
• Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol. 2001;28:2160–7.
   PubMed Web of Science ®Google Scholar
• Hempen CH, Fischer T. A Materia Medica for Chinese Medicine: Plants, Mineral and Animal Products. Munich: Elsevier Limited, 2009.
   Google Scholar
• Flanagan CM, Kaesberg JL, Mitchell ES, et al. Coronary artery aneurysm and thrombosis following chronic ephedra use. Int J Cardiol. 2010;139:e11–13.
   PubMed Web of Science ®Google Scholar
• Singhuber J, Zhu M, Prinz S, Kopp B. Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? J Ethnopharmacol. 2009;126:18–30.
   PubMed Web of Science ®Google Scholar
• Navarro R, Vilarrasa E, Herranz P, et al. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting. Br J Dermatol. 2013;168:609–16.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical Research Ed). 2010;340:c332.
   PubMed Web of Science ®Google Scholar
• Bartosińska JP, Pietrzak A, Szepietowski J, et al. Traditional Chinese medicine herbs - are they safe for psoriatic patients? Folia Histochemica Et Cytobiologica. 2011;49:201–5.
   PubMed Web of Science ®Google Scholar
• Ma H, Fan Q, Yu J, et al. Novel microemulsion of tanshinone IIA, isolated from salvia miltiorrhiza bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells. Am J Chin Med. 2013;41:197–210.
   PubMed Web of Science ®Google Scholar
• Li FL, Xu R, Zeng QC, et al. Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis. Evid Based Complement Alternat Med. 2012;2012:927658.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Beijing, China: People's Medical Publishing House, 2005.
   Google Scholar
• Kim HM, An CS, Jung KY, et al. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacol Res. 1999;40:171–6.
   PubMed Web of Science ®Google Scholar
• Wang H, Bian B, Yang J, Wang T. [Catalpol content changes in Rehmannia glutinosa (Gaertn.) Libosch. under certain conditions]. Zhongguo Zhong Yao Za Zhi. 1997;22:408–9.
   PubMedGoogle Scholar
• Gagnier JJ, Boon H, Rochon P, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144:364–7.
   PubMed Web of Science ®Google Scholar